Alachua, FL—AxoGen Inc., a company commercializing technology that repairs peripheral nerves, has raised a $12.1 million Series C round from Accuitive Medical Ventures, Cardinal Partners, DeNovo Ventures and Springboard Capital II.

In July 2007 the company introduceded its Avance product. Avance Nerve Graft is a human allograft nerve that supports axon regeneration along the repaired nerve.

The company says its technologies may help people who lose strength, movement and muscle mass due to a traumatic injury to the arm, lose the ability to smile due to a facial injury, or lose sexual function due to prostrate surgery or suffer other injuries or surgical damage to peripheral nerves.

“This round of funding will enable us to provide the Avance Nerve Graft to more surgeons, giving them a new solution to repair and regenerate peripheral nerves.

“Thus, Avance Nerve Graft will help bring relief and restore function to patients who suffer peripheral nerve injuries,” says Jamie Grooms, AxoGen CEO and co-founder.

Founded in 2002 AxoGen is based in Alachua, Florida.

On the Web: www.axogeninc.com

http://www.techjournalsouth.com/news/article.html?item_id=4392